Binary classification experiments on full sentences (negative or somewhat negative vs somewhat positive or positive with neutral sentences discarded) refer to the dataset as SST-2 or SST binary. The text in the dataset is in English (en). 'sentence': 'hide new secretions from the parental units ', 'label': 0} idx: Monotonically increasing index ID.

Soluble suppression of tumorigenicity-2 (sST2) is a biomarker widely investigated during the last few years. Its role has become clear in pathological conditions such as fibrosis and inflammation.

Oct 21, 2019 · sST2 is released in response to vascular congestion and inflammatory and profibrotic stimuli, and is a strong, independent predictor of mortality and HF hospitalization in patients with acute or chronic HF.

Feb 1, 2020 · Soluble suppression of tumorigenicity-2 (sST2) is a biomarker widely investigated during the last few years. Its role has become clear in pathological conditions such as fibrosis and inflammation.

Soluble suppression of tumorigenesis-2 (sST2) is released in response to vascular congestion and inflammatory and pro-fibrotic stimuli, and is a strong, independent predictor of mortality and heart failure (HF) hospitalization in patients with acute or chronic HF. sST2 meets 2 fundamental criteria for clinically useful biomarkers: accurate, repe...

A higher sST2 concentration (upper reference limit of 35 ng/ml) provides a substantial predictive risk of cardiovascular events, such as progressive LV failure, hospitalization for HF, and death .

ST2 (suppression of tumorigenicity 2) protein has gained interest as a potential biomarker in cardiovascular disease. It is known that the IL-33/ST2L system belongs to the cardioprotective pathway, which prevents the fibrosis, hypertrophy, and apoptosis of cardiomyocytes and also inhibits the inflammatory response.

Oct 29, 2019 · Soluble suppression of tumorigenesis-2 (sST2) is released in response to vascular congestion and inflammatory and pro-fibrotic stimuli, and is a strong, independent predictor of mortality and heart failure (HF) hospitalization in patients with acute or chronic HF. sST2 meets 2 fundamental criteria for clinically useful biomarkers: accurate, repe...

ST2 has two main isoforms, ST2L and soluble isoform of ST2 (sST2), by alternative splicing. The interaction between interleukin (IL)-33 and the transmembrane isoform ST2L is up-regulated in response to myocardial stress and exerts cardio-protective actions in …

Mar 30, 2015 · In this review, the role of sST2 as a HF biomarker will be discussed, specifically addressing analytical considerations of measuring sST2 as well as the clinical applications of measurement of sST2 for the diagnosis, prognosis and monitoring of acute and chronic HF.